Your browser is no longer supported. Please, upgrade your browser.
Settings
STJ St. Jude Medical Inc. daily Stock Chart
STJ [NYSE]
St. Jude Medical Inc.
IndexS&P 500 P/E19.79 EPS (ttm)3.59 Insider Own2.40% Shs Outstand281.74M Perf Week2.48%
Market Cap20.02B Forward P/E16.40 EPS next Y4.33 Insider Trans-6.60% Shs Float274.88M Perf Month-2.34%
Income1.04B PEG1.88 EPS next Q0.97 Inst Own86.00% Short Float2.53% Perf Quarter-2.74%
Sales5.57B P/S3.60 EPS this Y39.00% Inst Trans0.06% Short Ratio4.22 Perf Half Y5.80%
Book/sh13.66 P/B5.20 EPS next Y8.93% ROA10.50% Target Price81.95 Perf Year10.62%
Cash/sh3.23 P/C22.00 EPS next 5Y10.55% ROE25.90% 52W Range54.12 - 80.84 Perf YTD10.19%
Dividend1.16 P/FCF29.02 EPS past 5Y8.90% ROI12.90% 52W High-12.70% Beta1.38
Dividend %1.63% Quick Ratio0.90 Sales past 5Y3.70% Gross Margin70.90% 52W Low30.39% ATR1.93
Employees16000 Current Ratio1.10 Sales Q/Q-2.60% Oper. Margin25.40% RSI (14)47.89 Volatility2.92% 2.47%
OptionableYes Debt/Eq0.97 EPS Q/Q9.70% Profit Margin18.60% Rel Volume0.62 Prev Close71.06
ShortableYes LT Debt/Eq0.46 EarningsJul 22 BMO Payout30.70% Avg Volume1.65M Price70.57
Recom2.10 SMA20-0.29% SMA50-3.43% SMA2001.61% Volume540,166 Change-0.69%
Jul-23-15Reiterated Stifel Buy $81 → $89
Jul-23-15Reiterated RBC Capital Mkts Sector Perform $71 → $75
Jul-23-15Reiterated Barclays Overweight $84 → $86
Jul-23-15Downgrade Deutsche Bank Buy → Hold $76 → $77
Jul-21-15Reiterated Needham Strong Buy $86 → $91
Jul-08-15Upgrade Wells Fargo Market Perform → Outperform
Apr-23-15Upgrade Credit Suisse Neutral → Outperform $74 → $84
Apr-23-15Reiterated Stifel Buy $73 → $81
Apr-23-15Reiterated Canaccord Genuity Sell $54 → $64
Jan-16-15Reiterated Needham Strong Buy $78 → $84
Oct-16-14Reiterated Stifel Buy $75 → $66
Oct-16-14Reiterated Canaccord Genuity Sell $51 → $47
Sep-30-14Initiated Needham Strong Buy $78
Jul-17-14Reiterated Canaccord Genuity Sell $47 → $51
Jul-17-14Reiterated Barclays Overweight $75 → $78
Jul-08-14Initiated CRT Capital Buy $80
Apr-17-14Reiterated Canaccord Genuity Sell $51 → $47
Feb-10-14Upgrade Stifel Hold → Buy $75
Jan-23-14Reiterated Canaccord Genuity Sell $40 → $51
Jan-16-14Reiterated Barclays Overweight $72 → $75
Sep-03-15 10:59AM  Cramer: Medtronic to Go Higher, Joy Global to Go Lower at TheStreet
Sep-01-15 04:05PM  New St. Jude tech a boon for patients and New Mexico economy at bizjournals.com
Aug-30-15 10:34AM  Five Year Data from the FAME Trial Further Confirms the Sustained, Long Term Benefit of FFR-Guided PCI over Angiography-Guided Intervention Business Wire
04:11AM  LEADLESS II Trial Results Published in The New England Journal of Medicine Confirm the Positive Benefits of the Nanostim Leadless Pacemaker Business Wire
Aug-28-15 04:54PM  The Top 3 Medtech Buyout Rumors This Week at Investor's Business Daily
Aug-27-15 12:46PM  Stocks Rally to Erase Week's Losses at TheStreet
11:25AM  Abbott & St. Jude NO deal talk; Williams-Sonoma drops outlook; SolarCity upgraded
11:19AM  Stocks Extend Highs as S&P 500, Dow Recover From Correction at TheStreet
10:25AM  St. Jude Medical, Inc. (STJ) Shares Rally Following Mistaken Report Of Acquisition Bid From Abbott Laboratories (ABT) at Insider Monkey
10:21AM  Drugmaker Abbott says not pursuing an offer for St Jude Medical
10:20AM  Stocks Higher as July Pending Home Sales Climb at TheStreet
10:11AM  Dow, S&P 500, Nasdaq Markets Surge Higher at Open
10:06AM  Trending Now: STJ
10:03AM  This steep market swell may be dangerous to ride out at MarketWatch
09:45AM  Abbott denies $25bn bid for St Jude at Financial Times
09:39AM  St. Jude Medical (STJ) Stock Gains on Denied Report of Abbott Takeover Bid at TheStreet
09:11AM  Stock Futures Steer Higher; Retailers Struggle, St. Jude Soars at Investor's Business Daily
08:20AM  U.S. stocks ready to jump as China revives at MarketWatch
08:05AM  Abbott Labs not pursuing St. Jude: CNBC
08:00AM  Abbott denies rumors on St. Jude deal
07:51AM  Early movers: TIF, SJM, DG, MIK, CSX, TSLA & more at CNBC
Aug-24-15 02:45PM  ST JUDE MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
08:30AM  St. Jude Medical Receives CE Mark for Industry's Only MR-Conditional Rechargeable Spinal Cord Stimulator Approved to Offer Burst Stimulation Business Wire
Aug-18-15 05:50PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Thoratec Corp. of Commencement of a Class Action Concerning the Fairness of the Sale of the Company to St. Jude Medical, Inc. -- THOR Marketwired
Aug-13-15 01:04PM  ST JUDE MEDICAL INC Financials
12:50PM  Thoratec (THOR) Now a Strong Buy: Is It in Your Portfolio?
Aug-10-15 12:25PM  St. Jude Medical, Inc. Earnings Q2*, 2015
Aug-07-15 08:12PM  10-Q for St. Jude Medical, Inc. at Company Spotlight
Aug-06-15 01:40PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Thoratec Corp. of Commencement of a Class Action Concerning the Fairness of the Sale of the Company to St. Jude Medical, Inc. -- THOR GlobeNewswire
Aug-05-15 12:13PM  ST JUDE MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:30AM  St. Jude Medical Appoints David Dvorak to Its Board of Directors Business Wire
08:02AM  Stryker Corp. Earnings Q2*, 2015
Aug-04-15 05:35PM  St. Jude Medical Announces Third Quarter Dividend Business Wire
11:29AM  3 MedTech Stocks to Buy Before Their Q2 Earnings - Earnings ESP
Aug-03-15 11:11AM  The Top 3 ETFs For Investing in England at Investopedia
Jul-27-15 06:16PM  THORATEC CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
Jul-24-15 03:51PM  Thoratec Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thoratec Corporation PR Newswire
03:16PM  Converging On A Heartthrob Market
Jul-23-15 12:44PM  St. Jude Medical downgraded by Deutsche Bank
12:33PM  St. Jude Medical (STJ) Stock Downgraded at Deutsche Bank, BMO Capital at TheStreet
11:39AM  Breakout Watch: Abiomed Pumps Up Before Earnings at Investor's Business Daily
11:13AM  Why You Should Hold Your Bets On the St. Jude Medical, Inc. (STJ) and Thoratec Corporation (THOR) Merger at Insider Monkey
10:42AM  Breakout Watch: Abiomed Pumps Up Before Q2 Earnings
10:22AM  BMO Capital Downgrades St. Jude Medical On 'Less Compelling' Risk/Reward
Jul-22-15 04:26PM  Morgan & Morgan Announces the Investigation of Thoratec Corp. - THOR PR Newswire
03:54PM  Harwood Feffer LLP Announces Investigation of Thoratec Corporation PR Newswire
03:03PM  St. Jude Medical, Inc. -- Moody's reviews St. Jude Medical's Baa1 rating for downgrade at Moody's
02:21PM  Robbins Arroyo LLP: Acquisition of Thoratec Corp. (THOR) by St. Jude Medical, Inc. (STJ) May Not Be in Shareholders' Best Interests PR Newswire
12:52PM  St Jude Medical (STJ) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
12:45PM  Edited Transcript of STJ earnings conference call or presentation 22-Jul-15 12:00pm GMT
11:07AM  St. Jude Medical (STJ) Stock Gains Following Earnings Beat at TheStreet
10:28AM  St. Jude Medical Nabs Thoratec, Beats Q2 Estimates at Investor's Business Daily
09:45AM  Thoratec (THOR) Stock Jumps After St. Jude Medical Takeover Offer at TheStreet
09:37AM  ST JUDE MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
08:00AM  Early movers: BA, KO, XOM, CPB, WHR, Z & more at CNBC
07:10AM  Heart device maker St. Jude to buy Thoratec for $3.4 bln
07:07AM  Q2 2015 St. Jude Medical Inc Earnings Release - Before Market Open
07:05AM  St. Jude Medical Reports Second Quarter 2015 Results Business Wire
07:00AM  St. Jude Medical and Thoratec Announce Definitive Agreement Business Wire
Jul-21-15 06:16PM  St. Jude Medical's Penta Paddle Lead Labeling Gets FDA Nod - Analyst Blog
12:53PM  St. Jude Medical Said in Talks to Buy Thoratec
Jul-20-15 08:30AM  St. Jude Medical Announces FDA Approval for Industry's Only MR-Conditional 5-Column Paddle Lead for the Management of Chronic Pain Business Wire
Jul-16-15 08:30AM  St. Jude Medical Receives FDA Approval for the Industry's First Spinal Cord Stimulation Trial System to Incorporate Bluetooth® Wireless Technology and Apple Digital Devices Business Wire
Jul-11-15 02:18AM  [$$] Growth Stocks in the Lead at Barrons.com
Jul-08-15 10:37AM  Wells Fargo Ups St. Jude To Buy On Heartening Cardio Trends at Barrons.com
Jun-30-15 12:42PM  S&P Ups St. Jude Outlook To Stable at Barrons.com
08:30AM  St. Jude Medical Announces Launch of the First International Trial to Compare OCT-Guided Stent Implantation to IVUS or Angiography-Guided PCI Business Wire
Jun-25-15 09:15AM  St. Jude Medical Announces Second Quarter 2015 Earnings Conference Call Business Wire
Jun-24-15 05:19PM  Leadership Is Easy To Find In This Health Care Group at Investor's Business Daily
04:30PM  America's top states for innovation in 2015 at CNBC
09:37AM  St. Jude Medical CardioMEMS HF System Showcased at Premier, Inc.s 2015 Innovation Celebration Breakthroughs Conference Business Wire
Jun-15-15 08:03AM  Early movers: CVS, MU, LOW, BABA, TWTR & more at CNBC
Jun-08-15 10:05AM  St. Jude Medicals Axium System Found to Provide Superior Pain Relief Over Traditional Spinal Cord Stimulation for the Treatment of Chronic Lower Limb Pain Business Wire
Jun-05-15 08:00AM  Scientific Research Highlights St. Jude Medical's Comprehensive Chronic Pain Portfolio at the 12th INS World Congress Business Wire
Jun-04-15 08:00AM  St. Jude Medical Receives CE Mark Approval of Industry's First Neuromodulation Trial System to Employ Apple and Bluetooth Wireless Technology Business Wire
Jun-03-15 04:05PM  St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System Business Wire
Jun-01-15 04:23PM  House to take fresh aim at Obamacares medical device tax at MarketWatch
May-27-15 10:08AM  St. Jude Medical (STJ) Stock Coverage Initiated at Evercore ISI at TheStreet
May-26-15 09:18AM  3 Medical Device Stocks to Buy Right Now at TheStreet
May-20-15 04:19AM  New Data Further Emphasize the Clinical Benefits of St. Jude Medicals OCT Technology Business Wire
May-19-15 08:35AM  New Data Presented at EuroPCR 2015 Adds to the Growing Body of Clinical Evidence Supporting St. Jude Medical Fractional Flow Reserve Technology Business Wire
08:00AM  St. Jude Medical Announces Canadian Launch and First Implant of the Prodigy Spinal Cord Stimulation System with Burst Stimulation Business Wire
May-18-15 04:56PM  Taking the Pulse of Cardiac-Rhythm Management at Barrons.com
01:29PM  Jim Cramer -- St. Jude, Home Depot Lead Stocks in Second-Strongest Sectors at TheStreet
May-15-15 02:14PM  Data Shows the CardioMEMS HF System Adds Incremental Benefit When Combined With Device Therapy and Is Cost Effective Business Wire
01:58PM  Data Shows Improved Outcomes for Patients With St. Jude Medical Quadripolar CRT-P System Business Wire
May-14-15 02:57PM  New Outcomes and Cost Data Further Supports St. Jude Medical Leadership in Quadripolar Technology at HRS 2015 Business Wire
01:33PM  Data Show Remote Monitoring Technologies Significantly Lower Health Care Costs and Hospitalizations for Patients Business Wire
12:20PM  St. Jude Medical (STJ) MRI-Compatible Devices CE Marked - Analyst Blog
May-13-15 08:00AM  St. Jude Medical Expands Portfolio of MRI-Compatible Devices to High Voltage in Europe Business Wire
May-11-15 04:49PM  IPO Stock Watch: Nevro Soars On Q1 Beat, FDA Approval at Investor's Business Daily
May-09-15 08:09PM  10-Q for St. Jude Medical, Inc. at Company Spotlight
May-08-15 04:47PM  Stock Market Video Analysis 5/8/15
11:34AM  ST JUDE MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
May-07-15 04:37PM  ST JUDE MEDICAL INC Files SEC form 10-Q, Quarterly Report
May-06-15 08:20PM  St. Jude Medical Announces Dividend for Second Quarter of Fiscal Year 2015 at noodls
06:47PM  St. Jude Medical Announces Dividend for Second Quarter of Fiscal Year 2015 Business Wire
02:53PM  Brain technology patents soar as companies get inside people's heads
May-05-15 06:23PM  St. Jude Medical to Present at Bank of America Merrill Lynch 2015 Health Care Conference at noodls
04:15PM  St. Jude Medical to Present at Bank of America Merrill Lynch 2015 Health Care Conference Business Wire
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers tachycardia implantable cardioverter defibrillator systems and cardiac resynchronization therapy defibrillator devices to treat patients suffering from lethal heart conditions, such as sudden cardiac arrest or heart failure. It also provides pacemakers, which deliver low-voltage electrical impulses to stimulate a heartbeat for patients whose hearts beat too slowly; and atrial fibrillation products comprising electrophysiology, introducers and catheters, advanced cardiac mapping, navigation and recording systems, and ablation systems. In addition, the company offers vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, percutaneous catheter introducers, diagnostic guidewires, renal denervation technology and vascular plugs, optical coherence tomography imaging products, and other vascular accessories, as well as CardioMEMS, a heart failure monitoring device. Further, it provides structural heart products, including transcatheter aortic heart valves, various surgical heart valve repair and replacement products, and transcatheter structural heart defect devices; and neuromodulation products, such as spinal cord stimulation and radiofrequency ablation to treat chronic pain, as well as deep brain stimulation to treat movement disorders. The company sells its products through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fecho JeffVP, Global QualityJan 27Option Exercise35.277,075249,5358,912Jan 29 04:51 PM
STARKS DANIEL JChairman, CEO & PresidentJul 29Option Exercise40.55100,0004,055,0006,212,363Jul 31 04:30 PM
STARKS DANIEL JChairman, CEO & PresidentJul 29Sale73.93100,0007,393,0006,112,363Jul 31 04:30 PM
Zellers JasonVP, General Counsel & Corp SecMay 04Option Exercise41.6539616,4939,487May 06 04:15 PM
Zellers JasonVP, General Counsel & Corp SecMay 04Sale73.0439628,9249,091May 06 04:15 PM
Fecho JeffVP, Global QualityMay 01Option Exercise38.535,174199,3785,589May 05 04:37 PM
HILL BARBARA BDirectorMay 01Option Exercise40.403,229130,45221,232May 05 04:37 PM
HILL BARBARA BDirectorMay 01Sale71.143,229229,71118,003May 05 04:37 PM
Fecho JeffVP, Global QualityMay 01Sale71.475,174369,7863,489May 05 04:37 PM
STARKS DANIEL JChairman, CEO & PresidentApr 28Option Exercise40.55100,0004,055,0006,212,363Apr 30 05:25 PM
STARKS DANIEL JChairman, CEO & PresidentApr 28Sale72.46100,0007,245,8156,112,363Apr 30 05:25 PM
Murphy Mark W.VP, IT and CIOApr 27Option Exercise54.695,446297,8669,307Apr 28 04:35 PM
Murphy Mark W.VP, IT and CIOApr 27Sale72.375,446394,1273,861Apr 28 04:35 PM
Murphy Mark W.VP, IT and CIOApr 26Sale73.4743632,0333,861Apr 28 04:35 PM
HEINMILLER JOHN CExecutive Vice PresidentApr 24Option Exercise40.55160,0006,488,000396,828Apr 28 04:35 PM
Ellingson RachelVP, Global CommunicationsApr 24Option Exercise38.244,416168,8568,504Apr 28 04:34 PM
Thome ScottVP, Global Ops & Supply ChainApr 24Option Exercise35.275,632198,6417,583Apr 28 04:36 PM
Andrade LisaVP and Chief Marketing OfficerApr 24Option Exercise30.585,000152,90010,553Apr 28 04:31 PM
ESSIG STUARTDirectorApr 24Option Exercise43.207,750334,80041,667Apr 28 04:30 PM
Becker JoelPresident, AmericasApr 24Option Exercise55.6817,870995,03112,349Apr 28 04:32 PM
Carlson MarkChief Medical Off-VP,ClinicalApr 24Option Exercise30.587,000214,06012,016Apr 28 04:34 PM
Zellers JasonVP, General Counsel & Corp SecApr 24Option Exercise40.622,883117,0932,883Apr 28 04:33 PM
Fain Eric SGroup PresidentApr 24Option Exercise40.5547,0001,905,850122,585Apr 28 04:34 PM
Zellers JasonVP, General Counsel & Corp SecApr 24Sale74.133,566264,3520Apr 28 04:33 PM
Carlson MarkChief Medical Off-VP,ClinicalApr 24Sale73.727,000516,0405,016Apr 28 04:34 PM
Becker JoelPresident, AmericasApr 24Sale73.8717,8701,320,057143Apr 28 04:32 PM
ESSIG STUARTDirectorApr 24Sale73.857,750572,33833,917Apr 28 04:30 PM
Andrade LisaVP and Chief Marketing OfficerApr 24Sale73.875,000369,3505,553Apr 28 04:31 PM
Thome ScottVP, Global Ops & Supply ChainApr 24Sale74.055,632417,0501,951Apr 28 04:36 PM
Ellingson RachelVP, Global CommunicationsApr 24Sale74.004,416326,7844,088Apr 28 04:34 PM
Fain Eric SGroup PresidentApr 24Sale73.8447,0003,470,35175,585Apr 28 04:34 PM
HEINMILLER JOHN CExecutive Vice PresidentApr 24Sale73.69160,00011,790,400236,828Apr 28 04:35 PM
Andrade LisaVP and Chief Marketing OfficerApr 22Option Exercise40.555,000202,75010,553Apr 24 04:35 PM
Andrade LisaVP and Chief Marketing OfficerApr 22Sale70.555,000352,7505,553Apr 24 04:35 PM
Thome ScottVP, Global Ops & Supply ChainFeb 12Option Exercise38.592,50096,4754,451Feb 17 04:32 PM
Thome ScottVP, Global Ops & Supply ChainFeb 12Sale66.732,500166,8251,951Feb 17 04:32 PM
ROCCA MICHAEL ADirectorFeb 10Option Exercise43.203,875167,40022,702Feb 12 05:46 PM
ROCCA MICHAEL ADirectorFeb 10Sale65.573,875254,08418,827Feb 12 05:46 PM
ROUSSEAU MICHAEL TChief Operating OfficerFeb 06Sale67.317,207485,10319,182Feb 10 06:01 PM
ROCCA MICHAEL ADirectorFeb 04Option Exercise43.203,875167,40022,702Feb 06 04:35 PM
ROCCA MICHAEL ADirectorFeb 04Sale67.263,875260,63318,827Feb 06 04:35 PM
Thome ScottVP, Global Ops & Supply ChainFeb 03Option Exercise34.966,666233,0438,617Feb 05 04:31 PM
Zellers JasonVP, General Counsel & Corp SecFeb 03Option Exercise38.5990034,7319,991Feb 05 04:31 PM
Gestin Denis MPresident, InternationalFeb 03Option Exercise36.30148,5005,391,165193,282Feb 05 04:30 PM
Zellers JasonVP, General Counsel & Corp SecFeb 03Sale67.5090060,7509,091Feb 05 04:31 PM
Thome ScottVP, Global Ops & Supply ChainFeb 03Sale67.946,666452,8881,951Feb 05 04:31 PM
Gestin Denis MPresident, InternationalFeb 03Sale67.13148,5009,968,80518,282Feb 05 04:30 PM
DEVENUTI RICHARD RDirectorFeb 02Option Exercise43.207,450321,84035,898Feb 03 06:20 PM
Murphy Mark W.VP, IT and CIOFeb 02Sale66.9285957,4843,002Feb 04 05:36 PM
DEVENUTI RICHARD RDirectorFeb 02Sale66.457,450495,04628,448Feb 03 06:20 PM
Fecho JeffVP, Global QualityJan 30Option Exercise35.169,333328,1429,489Feb 03 06:18 PM
WIDENSOHLER STEFAN KDirectorJan 30Option Exercise43.207,750334,80027,631Feb 03 06:18 PM
Becker JoelPresident, AmericasJan 30Option Exercise35.1337,9161,332,13131,017Feb 03 06:19 PM
DEVENUTI RICHARD RDirectorJan 30Option Exercise43.2030012,96028,748Feb 03 06:20 PM
DEVENUTI RICHARD RDirectorJan 30Sale66.0030019,80028,448Feb 03 06:20 PM
Becker JoelPresident, AmericasJan 30Sale65.8647,6833,140,5110Feb 03 06:19 PM
WIDENSOHLER STEFAN KDirectorJan 30Sale66.177,750512,81819,881Feb 03 06:18 PM
Fecho JeffVP, Global QualityJan 30Sale65.889,333614,8583,489Feb 03 06:18 PM
BROWN JOHN WDirectorJan 13Option Exercise40.8464,5002,634,390117,623Jan 15 04:46 PM
HEINMILLER JOHN CExecutive Vice PresidentDec 18Sale64.606,853442,678236,828Dec 19 04:41 PM
Zurbay DonaldVP Finance and CFODec 18Sale66.2264742,84416,880Dec 19 04:42 PM
Thome ScottVP, Global Ops & Supply ChainOct 30Option Exercise35.275,632198,6415,632Nov 03 05:01 PM
Craig Angela DVP - Global Human ResourcesOct 30Option Exercise34.9620,000699,20024,941Nov 03 05:01 PM
Ellingson RachelVP, Corporate RelationsOct 30Option Exercise37.795,369202,8977,463Nov 03 05:01 PM
Ellingson RachelVP, Corporate RelationsOct 30Sale61.845,369332,0193,127Nov 03 05:01 PM
Thome ScottVP, Global Ops & Supply ChainOct 30Sale64.225,632361,6870Nov 03 05:01 PM
Craig Angela DVP - Global Human ResourcesOct 30Sale64.1220,0001,282,4004,941Nov 03 05:01 PM
Zurbay DonaldVP Finance and CFOOct 29Option Exercise38.5938,0001,466,42051,740Oct 31 04:37 PM
Dallager JeffVP and Corporate ControllerOct 29Option Exercise36.9019,597723,09512,405Oct 31 04:36 PM
Zurbay DonaldVP Finance and CFOOct 29Sale61.7138,0002,344,98013,740Oct 31 04:37 PM
Dallager JeffVP and Corporate ControllerOct 29Sale61.6819,5971,208,7432,405Oct 31 04:36 PM
Fecho JeffVP, Global QualityOct 27Sale60.5550030,2751,452Oct 29 05:00 PM
Zellers JasonVP, General Counsel & Corp SecOct 23Option Exercise35.631,58456,4401,624Oct 27 04:45 PM
Zellers JasonVP, General Counsel & Corp SecOct 23Option Exercise35.1431,9991,124,47224,168Oct 27 04:45 PM
Zellers JasonVP, General Counsel & Corp SecOct 23Sale60.002,000120,000792Oct 27 04:45 PM
Zellers JasonVP, General Counsel & Corp SecOct 23Sale60.0431,9991,921,2205,502Oct 27 04:45 PM
STARKS DANIEL JChairman, CEO & PresidentOct 22Option Exercise30.58100,0003,058,0006,201,625Oct 24 04:34 PM
STARKS DANIEL JChairman, CEO & PresidentOct 22Sale60.04100,0006,004,0006,101,625Oct 24 04:34 PM
Andrade LisaVP and Chief Marketing OfficerOct 21Option Exercise38.004,000152,0007,841Oct 23 03:58 PM
Andrade LisaVP and Chief Marketing OfficerOct 21Sale60.004,000240,0003,841Oct 23 03:58 PM